Thorvardur Halfdanarson MD

Thorvardur R. Halfdanarson, MD., is a medical oncologist at Mayo Clinic who also researches various types of cancer, including pancreatic cancer and neuroendocrine tumors. His specific research interests include the epidemiology, risk factors, and treatment of neuroendocrine tumors and improving outcomes for pancreatic adenocarcinoma and rare types of pancreatic tumors. He is a principal investigator and co-investigator for multiple industry-sponsored and cooperative group clinical trials.

Dr. Halfdanarson holds several leadership positions within Mayo Clinic Comprehensive Cancer Center. He is chair of the Hepato-Pancreatico-Biliary Cancer Disease Group and co-chair of the Pancreatic eTumor Board. He is associate medical director of the Cancer Clinical Trials Office in Rochester, Minnesota, co-chair of the Feasibility Committee, and a member of the Clinical Research Leadership Committee. He also represents Mayo Clinic on the Neuroendocrine Tumors Guidelines Panel of the National Comprehensive Cancer Network (NCCN).